[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100191805":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":21,"responsibleParty":40,"collaborators":42,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":7,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":7,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Centers for Disease Control and Prevention","FED",null,[9],{"name":10,"affiliation":5,"role":11},"Paul Mehta, MD","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","770-488-0556","PMehta1@cdc.gov",{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},"Kevin Horton, DrPH, MSPH","770-488-1555","dhorton@cdc.gov",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"CDC","RECRUITING","Atlanta","Georgia","30333","United States","US",{"type":31,"coordinates":32},"Point",[33,34],-84.38798,33.749,{"lat":34,"lon":33},[37,38,39],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"name":18,"role":14,"phone":19,"phoneExt":7,"email":20},{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[43,45],{"name":44,"class":6},"US Department of Veterans Affairs",{"name":46,"class":6},"Centers for Medicare and Medicaid Services","100191805","the-national-amyotrophic-lateral-sclerosis-registry-100191805",false,"NCT01772602","The National Amyotrophic Lateral Sclerosis Registry","Inclusion Criteria:\n\n\\- U.S. citizens 18 years of age or older\n\nExclusion Criteria:\n\n\\-","ALL","18 Years",{"count":56,"type":57},30000,"ESTIMATED","5 Years","OBSERVATIONAL","The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.",[62],"Amyotrophic Lateral Sclerosis",[62,64,65],"Lou Gehrig's Disease","Motor Neuron Disease","2026-04-24",{"date":68,"type":69},"2026-04-29","ACTUAL",{"date":71,"type":7},"2010-10",{"date":73,"type":57},"2040-12",{"name":5,"class":6},1]